Drugs used to treat diabetes could also be used to treat Alzheimer’s disease (AD), and vice versa, according to new research from the University of Aberdeen in Scotland. It’s the first study to show that AD can lead to diabetes, as opposed to diabetes occurring first, as was previously thought.
The investigators found that AD and type-2 diabetes are so closely related that drugs currently used to control glucose levels in diabetes may also alleviate the symptoms and progression of AD.
The study, published in Diabetologia, found for the first time that dementia-related complications within the brain can also lead to changes in glucose handling and ultimately diabetes. This is contrary to what was previously thought––that diabetes begins with a malfunction in the pancreas or with a high-fat, high-sugar diet.
The research team, led by Professor Bettina Platt, set out to investigate why AD and diabetes are commonly found together in elderly patients. They developed a model of AD and were surprised to find that increased levels of a gene involved in the production of toxic proteins in the brain not only led to Alzheimer’s-like symptoms, but also to the development of diabetic complications.
“Many people are unaware of the relationship between diabetes and Alzheimer’s disease, but the fact is that around 80% of people with Alzheimer’s disease also have some form of diabetes or disturbed glucose metabolism,” Platt said. “This is hugely relevant as Alzheimer’s is in the vast majority of cases not inherited, and lifestyle factors and comorbidities must therefore be to blame.
“Our research teams are particularly interested in the impact of lifestyle-related factors in dementia, and by collaborating with experts in diabetes and metabolism, we have been able to investigate the nature of the link in great detail.
“Until now, we always assumed that obese people get type-2 diabetes and then are more likely to get dementia. We now show that actually it also works the other way around.
“Additionally, it was previously believed that diabetes starts in the periphery, i.e. the pancreas and liver, often due to consumption of an unhealthy diet, but here we show that dysregulation in the brain can equally lead to development of very severe diabetes––again showing that diabetes doesn’t necessarily have to start with your body getting fat; it can start with changes in the brain.
“This study provides a new therapeutic angle into Alzheimer’s disease, and we now think that some of the compounds that are used for obesity and diabetic deregulation might potentially be beneficial for Alzheimer’s patients as well. The good news is that there are a number of new drugs available right now which we are testing to see if they would reverse both Alzheimer’s and diabetes symptoms. We will also be able to study whether new treatments developed for Alzheimer’s can improve both the diabetic and cognitive symptoms.”
Source: University of Aberdeen (link is external); June 21, 2016.
Our most popular topics on Managedcaremag.com
Paul Lendner ist ein praktizierender Experte im Bereich Gesundheit, Medizin und Fitness. Er schreibt bereits seit über 5 Jahren für das Managed Care Mag. Mit seinen Artikeln, die einen einzigartigen Expertenstatus nachweisen, liefert er unseren Lesern nicht nur Mehrwert, sondern auch Hilfestellung bei ihren Problemen.